Overcoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation.
作者信息
Pruis Melinda A, Paats M S, Geurts W R R, Dubbink H J, Dingemans A-M C
机构信息
Department of Respiratory Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
出版信息
JCO Precis Oncol. 2021 Nov;5:849-853. doi: 10.1200/PO.21.00076.
PMID:34994615
Abstract
摘要
Zotero 插件